Italy· 032311211
ZOLISTAM*20 cpr 10 mg rilascio modificato
A mizolastine product containing mizolastina, registered in Italy by OPELLA HEALTHCARE ITALY Srl, on the national reimbursement list. The same ATC class is registered in 7 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Mizolastine is registered in 7 of 19 countries.
Countries holding a registration under ATC R06AX25 (mizolastine), each read from that country’s own register.
- This record: Italy
- 4 of them publish a price we can compare per daily dose
Mizolastine · ATC R06AX25
7 / 19 countries
- Belgiumprice
- Finlandprice
- Franceprice
- Germany
- Italyprice
- Netherlands
- United Kingdom
Price per daily dose
What a daily dose of mizolastine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.31 in France to $0.55 in Spain — a ×1.8 gap.
- Italy: $0.42 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Mizolastine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- ES Spain$0.55
- IT Italy$0.42
- FR France$0.31
The record
At a glance
- Active substance
- Mizolastina
- Manufacturer
- OPELLA HEALTHCARE ITALY Srl
- Country
- Italy (IT)
- ATC code
- R06AX25
- ATC class
- Mizolastine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic032311211ZOLISTAM*20 cpr 10 mg rilascio modificatoEUR 7.34
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mizolastine in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandMistamineGalderma Nordic AB
- SpainMIZOLEN 10 mg COMPRIMIDOS DE LIBERACION MODIFICADAOpella Healthcare Spain S.L.
- FranceMIZOCLER 10 mg, comprimé pelliculé à libération modifiéeDESMA PHARMA
- United KingdomMistamine 10mg modified-release tabletsGalderma (UK) Ltd
- GermanyMizollenA. Nattermann & Cie. Gmbh
- NetherlandsMizollen 10 mg, tabletten met gereguleerde afgifteOpella Healthcare France S.A.S.
- BelgiumMizollen 10 mgOpella Healthcare Belgium
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Mizollen
- France · Mizocler, Mizollen
- Greece · Oriens
- Netherlands · Mizollen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fec58bd0-66f7-4a71-a0aa-28e6acf2f5d8 GET /v1/drugs/fec58bd0-66f7-4a71-a0aa-28e6acf2f5d8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 7.34,
"source": "aifa",
"currency": "EUR",
"strength": "MIZOLASTINA 10MG 20 UNITA' USO ORALE RM",
"substance": "Mizolastina",
"equivalence_group": "P1A",
"transparency_flag": null
}See everything about mizolastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.